There has been a shortage of Fabrazyme — the medication used to treat Fabry's disease — for more than a year, as the maker, Genzyme, struggles with manufacturing problems, says Pharmalot's Ed Silverman.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.